Matches in SemOpenAlex for { <https://semopenalex.org/work/W4231782559> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4231782559 endingPage "ec289" @default.
- W4231782559 startingPage "ec289" @default.
- W4231782559 abstract "Breakdown of tryptophan to kynurenine by the enzyme indoleamine-2,3-dioxygenase (IDO) inhibits T cell responses and promotes immune tolerance. Tryptophan degradation by IDO in tumor cells is associated with immune evasion and increased tumor growth (see commentary by Prendergast). Thus, better understanding of how tryptophan catabolism affects immune responses might help to develop anticancer therapies. Opitz et al. found that cultured human glioma cell lines and glioma-initiating cells degraded tryptophan and produced large quantities of kynurenine. Knockdown of IDO isoforms in these cells had no effect on tryptophan metabolism; rather, knockdown of another tryptophan-degrading enzyme, TDO, blocked production of kynurenine. Immunohistochemical analysis showed that the abundance of TDO correlated with malignancy in human brain tumors. The amount of kynurenine produced by glioma cells correlated with inhibition of the proliferation of cocultured T cells. Knockdown of TDO in glioma cells restored T cell proliferation, whereas T cell proliferation was inhibited by the addition of exogenous kynurenine. The growth of TDO knockdown tumors implanted in the brains of nude mice was impeded compared to that of tumors proficient in TDO. Microarray analysis of kynurenine-treated glioma cells revealed the enhanced expression of many aryl hydrocarbon receptor (AHR)–responsive genes. The AHR is a transcription factor that responds to xenobiotic compounds, such as dioxin, to suppress immune responses and stimulate tumorigenesis. AHR-responsive gene expression in glioma cells was decreased when TDO was knocked down, suggestive of autocrine AHR signaling. However, when injected into Ahr-deficient mice, Tdo-expressing tumor cells exhibited attenuated growth, suggesting that paracrine AHR signaling was also required for tumor progression. Microarray analysis showed that expression of TDO correlated with that of AHR-responsive genes in many different cancer types, and high expression of TDO, AHR, or the AHR-responsive gene CYP1B1 correlated with poor survival of glioma patients. Together, these data suggest that TDO-derived kynurenine acts in an autocrine and paracrine fashion through the AHR to promote tumor growth." @default.
- W4231782559 created "2022-05-12" @default.
- W4231782559 creator A5040603302 @default.
- W4231782559 date "2011-10-18" @default.
- W4231782559 modified "2023-10-17" @default.
- W4231782559 title "Tryptophan Fix" @default.
- W4231782559 doi "https://doi.org/10.1126/scisignal.4195ec289" @default.
- W4231782559 hasPublicationYear "2011" @default.
- W4231782559 type Work @default.
- W4231782559 citedByCount "0" @default.
- W4231782559 crossrefType "journal-article" @default.
- W4231782559 hasAuthorship W4231782559A5040603302 @default.
- W4231782559 hasConcept C104317684 @default.
- W4231782559 hasConcept C173396325 @default.
- W4231782559 hasConcept C190283241 @default.
- W4231782559 hasConcept C203014093 @default.
- W4231782559 hasConcept C2776706248 @default.
- W4231782559 hasConcept C2776710720 @default.
- W4231782559 hasConcept C2777503454 @default.
- W4231782559 hasConcept C2778227246 @default.
- W4231782559 hasConcept C33594762 @default.
- W4231782559 hasConcept C502942594 @default.
- W4231782559 hasConcept C515207424 @default.
- W4231782559 hasConcept C55493867 @default.
- W4231782559 hasConcept C62112901 @default.
- W4231782559 hasConcept C83478079 @default.
- W4231782559 hasConcept C86339819 @default.
- W4231782559 hasConcept C86803240 @default.
- W4231782559 hasConcept C8891405 @default.
- W4231782559 hasConcept C95444343 @default.
- W4231782559 hasConceptScore W4231782559C104317684 @default.
- W4231782559 hasConceptScore W4231782559C173396325 @default.
- W4231782559 hasConceptScore W4231782559C190283241 @default.
- W4231782559 hasConceptScore W4231782559C203014093 @default.
- W4231782559 hasConceptScore W4231782559C2776706248 @default.
- W4231782559 hasConceptScore W4231782559C2776710720 @default.
- W4231782559 hasConceptScore W4231782559C2777503454 @default.
- W4231782559 hasConceptScore W4231782559C2778227246 @default.
- W4231782559 hasConceptScore W4231782559C33594762 @default.
- W4231782559 hasConceptScore W4231782559C502942594 @default.
- W4231782559 hasConceptScore W4231782559C515207424 @default.
- W4231782559 hasConceptScore W4231782559C55493867 @default.
- W4231782559 hasConceptScore W4231782559C62112901 @default.
- W4231782559 hasConceptScore W4231782559C83478079 @default.
- W4231782559 hasConceptScore W4231782559C86339819 @default.
- W4231782559 hasConceptScore W4231782559C86803240 @default.
- W4231782559 hasConceptScore W4231782559C8891405 @default.
- W4231782559 hasConceptScore W4231782559C95444343 @default.
- W4231782559 hasIssue "195" @default.
- W4231782559 hasLocation W42317825591 @default.
- W4231782559 hasOpenAccess W4231782559 @default.
- W4231782559 hasPrimaryLocation W42317825591 @default.
- W4231782559 hasRelatedWork W2097156202 @default.
- W4231782559 hasRelatedWork W2146914242 @default.
- W4231782559 hasRelatedWork W2156805729 @default.
- W4231782559 hasRelatedWork W2306638524 @default.
- W4231782559 hasRelatedWork W4200323365 @default.
- W4231782559 hasRelatedWork W4206597252 @default.
- W4231782559 hasRelatedWork W4230169520 @default.
- W4231782559 hasRelatedWork W4282941657 @default.
- W4231782559 hasRelatedWork W4311135951 @default.
- W4231782559 hasRelatedWork W2330282954 @default.
- W4231782559 hasVolume "4" @default.
- W4231782559 isParatext "false" @default.
- W4231782559 isRetracted "false" @default.
- W4231782559 workType "article" @default.